We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
The first findings from a series of medicinal cannabis trials have revealed that Cannabidiol (CBD) oil does not improve pain, depression, anxiety nor quality of life ...
Mater Researchers have launched a trial to discover if laser light therapy can relieve some of the debilitating symptoms of IBD in young people.
This International Clinical Trials Day, Friday 20 May 2022, Mater is shining a light on the more than 200 clinical trials being run through Mater Research and Mater ...
Mater Research is calling for 50 adults in south-east Queensland to join the global clinical trial of a potential new protein-based COVID-19 vaccine, the latest ...
World Clinical Trials Day seeks to recognise the doctors, nurses and scientists who conduct clinical trials and thank them for the significant impact they have on ...
During a world first therapy conducted at the Princess Alexandra Hospital by Mater Researcher and Haematologist Professor Maher Gandhi a 46-year-old patient Scott ...
A vaccine for childhood respiratory viral infections is a step closer after an Mater Research Institute—UQ (MRI—UQ) immunopathology specialist was awarded a ...
A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.
A Queensland trial will evaluate the benefits of medicinal cannabis for symptom relief in cancer patients receiving palliative care.